ORAL THERAPIES FOR DIABETIC HYPERGLYCEMIA

This publication has 63 references indexed in Scilit:

• Insulin Resistance and Its Treatment by Thiazolidinediones
  Recent Progress in Hormone Research, 2001
• Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety Study
  The Journal of Clinical Pharmacology, 2000
• Rosiglitazone
  Drugs, 1999
• Efficacy, Safety, and Dose-Response Characteristics of Glipizide Gastrointestinal Therapeutic System on Glycemic Control and Insulin Secretion in NIDDM: Results of two multicenter, randomized, placebo-controlled clinical trials
  Diabetes Care, 1997
• Glimepiride, a New Once-Daily Sulfonylurea: A double-blind placebo-controlled study of NIDDM patients
  Diabetes Care, 1996
• The Effect of Glimepiride on Pancreatic β-Cell Function Under Hyperglycaemic Clamp and Hyperinsulinaemic, Euglycaemic Clamp Conditions in Non-Insulin-Dependent Diabetes Mellitus
  Hormone and Metabolic Research, 1996
• An Overview of the Safety and Tolerance of Glimepiride
  Hormone and Metabolic Research, 1996
• Worldwide Experience of Metformin as an Effective Glucose-lowering Agent: A Meta-analysis
  Diabetes/Metabolism Research and Reviews, 1995
• Comparative Efficacy of a Once-Daily Controlled-Release Formulation of Glipizide and Immediate-Release Glipizide in Patients With NIDDM
  Diabetes Care, 1994
• Abnormal Patterns of Insulin Secretion in Non-Insulin-Dependent Diabetes Mellitus
  New England Journal of Medicine, 1988